Day: June 28, 2022

Of the patients with SD, two patients had melanoma, two had renal cell carcinoma, two had mesothelioma and one had a uterine cancer. tumor malignancies received weekly intravenous infusions of CP-870,893 in four dose level cohorts. Security and immune pharmacodynamics were assessed. Conclusions Weekly infusions of the agonist CD40 antibody CP-870,893 were well-tolerated, but there […]